Published in J Clin Pathol on August 01, 1989
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics (2008) 1.14
Proteomics in molecular diagnosis: typing of amyloidosis. J Biomed Biotechnol (2011) 1.08
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics. Haematologica (2014) 1.00
Micropurification techniques in the analysis of amyloid proteins. J Clin Pathol (2003) 0.81
Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol (1975) 36.95
Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science (1971) 4.27
Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci U S A (1978) 3.10
The major proteins of human and monkey amyloid substance: Common properties including unusual N-terminal amino acid sequences. FEBS Lett (1971) 3.09
Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun (1983) 2.16
Senile cardiac amyloid is related to prealbumin. Scand J Immunol (1980) 1.86
A new method for the diagnosis of systemic amyloidosis. Arch Intern Med (1973) 1.38
Identification and characterization of different amyloid fibril proteins in tissue sections. Scand J Immunol (1977) 1.33
Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Arch Intern Med (1983) 1.08
Immunocytochemical identification of amyloid in formalin-fixed paraffin sections. Histochemistry (1981) 1.02
Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine. Am J Med (1985) 0.99
Structure and antigenic behaviour of kappa I-immunoglobulin light-chain amyloid proteins. Acta Pathol Microbiol Scand C (1981) 0.91
Abdominal fat tissue aspirate in human amyloidosis: light, electron, and immunofluorescence microscopic studies. Hum Pathol (1986) 0.85
Demonstration of protein AA in subcutaneous fat tissue obtained by fine needle biopsy. Ann Rheum Dis (1979) 0.85
Primary amyloidosis associated with multiple myeloma. Predictors of successful therapy. Am J Med (1986) 0.83
Immunochemical typing of amyloid from tissue biopsies. Acta Histochem Suppl (1982) 0.80
Diagnostic value of abdominal fat tissue aspirate in familial amyloid polyneuropathy. J Neurol Sci (1987) 0.80
Simple method of diagnostic screening for amyloidosis. Ann Rheum Dis (1974) 0.79
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
Multiple forms of cytochrome c in the rat. Precursor-product relationship between the main component Cy I and the minor components Cy II and Cy 3 in vivo. J Biol Chem (1968) 2.76
Cloning and sequencing of the gene encoding the phosphatidylcholine-preferring phospholipase C of Bacillus cereus. Gene (1988) 2.74
Service profiling and outcomes benchmarking using the CORE-OM: toward practice-based evidence in the psychological therapies. Clinical Outcomes in Routine Evaluation-Outcome Measures. J Consult Clin Psychol (2001) 2.72
A novel lactococcal bacteriocin whose activity depends on the complementary action of two peptides. J Bacteriol (1992) 2.58
Obesity among Navajo adolescents. Relationship to dietary intake and blood pressure. Am J Dis Child (1992) 2.30
A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun (1986) 2.24
Neuroimaging and obesity: current knowledge and future directions. Obes Rev (2011) 2.23
Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun (1988) 2.13
Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex. Infect Immun (1990) 2.06
Purification and amino acid sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45. Appl Environ Microbiol (1991) 2.02
The complete amino-acid sequence of non-immunoglobulin amyloid fibril protein AS in rheumatoid arthritis. Eur J Biochem (1974) 2.02
Antigenic and chemical characterization of non-immunoglobulin amyloid proteins. Scand J Immunol (1972) 1.97
Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med (1976) 1.91
Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Appl Environ Microbiol (1995) 1.90
Purification and amino acid sequence of a bacteriocin produced by Pediococcus acidilactici. J Gen Microbiol (1992) 1.89
Senile cardiac amyloid is related to prealbumin. Scand J Immunol (1980) 1.86
Purification and N-terminal sequence of a fimbrial protein from Moraxella nonliquefaciens. FEBS Lett (1977) 1.81
New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity. Appl Environ Microbiol (1996) 1.61
Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry (1995) 1.61
Lytic and turbid plaque-type mutants of lymphocytic choriomeningitis virus as a cause of neurological disease or persistent infection. Infect Immun (1971) 1.56
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. Eur J Immunol (1996) 1.53
Percutaneous pericardial catheter drainage in childhood. Am J Cardiol (1992) 1.45
Amyloid-related serum protein SAA from three animal species: comparison with human SAA. J Immunol (1977) 1.43
Chemical characterization of high potential iron proteins from Chromatium and Rhodopseudomonas gelatinosa. Biochim Biophys Acta (1967) 1.42
Amyloid fibril protein subunit, "protein AS": distribution in tissue and serum in different clinical types of amyloidosis including that associated with myelomatosis and Waldenström's macroglobulinamia. Scand J Immunol (1973) 1.41
In vivo conversion of L-serine to D-alanine in a ribosomally synthesized polypeptide. J Biol Chem (1994) 1.40
Some characteristics of phospholipase C from Bacillus cereus. Eur J Biochem (1977) 1.32
Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr (1996) 1.32
Purification and characterization of a new bacteriocin isolated from a Carnobacterium sp. Appl Environ Microbiol (1992) 1.30
Unique amyloid protein subunit common to different types of amyloid fibril. Nature (1973) 1.30
Balloon aortic valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol (1990) 1.29
Purification and characterization of plantaricin A, a Lactobacillus plantarum bacteriocin whose activity depends on the action of two peptides. J Gen Microbiol (1993) 1.29
Cytochrome c2 of Rhodospirillum rubrum. II. Complete amino acid sequence and phylogenetic relationships. J Biol Chem (1968) 1.27
New, third class of amyloid fibril protein. J Exp Med (1974) 1.25
Protein kinase C and cyclic AMP-dependent protein kinase phosphorylate phospholemman, an insulin and adrenaline-regulated membrane phosphoprotein, at specific sites in the carboxy terminal domain. Biochem J (1994) 1.24
Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg (1998) 1.24
Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci U S A (1999) 1.24
Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J Ethnopharmacol (2000) 1.23
Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics (1992) 1.22
The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR. Biochem J (1981) 1.22
An unusually large (83 amino acid residues) amyloid fibril protein AA from a patient with Waldenström's macroglobulinaemia and amyloidosis. Scand J Immunol (1980) 1.21
Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol (2001) 1.19
Antibody formation in persistent tolerant infection with lymphocytic choriomeningitis virus. Nature (1969) 1.16
The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol (1988) 1.16
Chemical and clinical classification of amyloidosis 1985. Scand J Immunol (1986) 1.14
A new prealbumin variant in familial amyloid cardiomyopathy of Danish origin. Scand J Immunol (1988) 1.13
Specific food intolerance: its place as a cause of gastrointestinal symptoms. Gut (1985) 1.11
N-terminal amino acid sequence of amyloid fibril protein AR, prototype of a new lambda-variable subgroup, V lambda V. Scand J Immunol (1974) 1.10
The Fontan procedure: analysis of cohorts and late complications. Cardiol Young (2000) 1.09
Association of the lactococcin A immunity factor with the cell membrane: purification and characterization of the immunity factor. J Gen Microbiol (1993) 1.08
Chemical dependency allegations and the Minnesota Board of Medical Practice. Minn Med (1993) 1.07
Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting. Pediatr Neurol (2000) 1.07
The detection of neutralizing antibody to lymphocytic choriomeningitis virus in mice. J Immunol (1969) 1.06
An additional mitochondrial tRNA(Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat (1996) 1.05
Pulmonary vascular amyloidosis in aged dogs. A new form of spontaneously occurring amyloidosis derived from apolipoprotein AI. Am J Pathol (1992) 1.04
Ambulatory blood pressure monitoring and left ventricular mass and function after successful surgical repair of coarctation of the aorta. J Am Coll Cardiol (1992) 1.03
Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med (1987) 1.03
Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol (1985) 1.03
Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3. Am J Pathol (2001) 1.03
Coexistence of protein AA and immunoglobulin light-chain fragments in amyloid fibrils. Scand J Immunol (1976) 1.03
Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene. Am J Hum Genet (1994) 1.03
Balloon angioplasty of recurrent coarctation: a 12-year review. J Am Coll Cardiol (1997) 1.02
Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes. Int J Cardiol (2006) 1.02
An experimental model in mink for studying the relation between amyloid fibril protein AA and the related serum protein SAA. Scand J Immunol (1975) 1.02
Noncompaction of the myocardium associated with Roifman syndrome. Cardiol Young (2001) 1.01
Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart (2004) 1.01
A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab (1987) 1.01
Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem Biophys Res Commun (1998) 1.00
Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages. J Biol Chem (1983) 1.00
Cytochrome c2 of Rhodospirillum rubrum. 1. Molecular properties of the protein and amino acid sequences of its peptides derived by the action of trypsin and thermolysin. J Biol Chem (1968) 1.00
Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am J Pathol (1995) 1.00
Amyloid fibril protein AA. Characterization of uncommon subspecies from a patient with rheumatoid arthritis. Lab Invest (1987) 0.99
Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin Exp Immunol (1982) 0.99
Pulsed Doppler assessment of pulmonary vein obstruction. Am Heart J (1985) 0.99
Translocation of diphtheria toxin A-fragment to the cytosol. Role of the site of interfragment cleavage. J Biol Chem (1989) 0.98
Alternative, non-immunoglobulin origin of amyloid fibrils. Nat New Biol (1972) 0.98
Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol (2001) 0.98
Prealbumin variants in the amyloid fibrils of Swedish familial amyloidotic polyneuropathy. Clin Exp Immunol (1987) 0.97
Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol (2005) 0.97
Fluorometric analysis of transferable membrane pores. Biochemistry (1985) 0.97
Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart (2000) 0.97
Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diabetes Res Clin Pract (1989) 0.97
Homology between the MPB70 and MPB83 proteins of Mycobacterium bovis BCG. Scand J Immunol (1995) 0.96
Structural studies of a carbohydrate-containing immunoglobulin-lambda-light-chain amyloid-fibril protein (AL) of variable subgroup III. Biochem J (1986) 0.96
Feline insular amyloid: immunohistochemical and immunochemical evidence that the amyloid is insulin-related. Vet Pathol (1985) 0.96
Positron emission tomography. The technique and its applications to the study of the cardiovascular system. Cardiol Clin (1983) 0.96
Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol (1998) 0.95
Extensive intimal apolipoprotein A1-derived amyloid deposits in a patient with an apolipoprotein A1 mutation. Biochem Biophys Res Commun (1998) 0.95
Bupivacaine use after knee arthroscopy: pharmacokinetics and pain control study. Arthroscopy (1990) 0.95
Successful percutaneous treatment of anomalous left coronary artery from pulmonary artery. Int J Cardiol (2007) 0.94
The amino acid sequence of a carbohydrate-containing immunoglobulin-light-chain-type amyloid-fibril protein. Biochem J (1985) 0.94
Noninvasive recognition of functional pulmonary atresia by echocardiography. Am J Cardiol (1984) 0.93
Partial amino acid sequence analysis and variable subgroup determination (VH and VL) of a monoclonal rheumatoid factor derived from a rheumatoid arthritis patient. Scand J Rheumatol Suppl (1988) 0.93
Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience. Pediatr Transplant (2001) 0.93
Magnetic resonance imaging in primary amyloidosis. Acta Radiol (1987) 0.93
Further structural and antigenic studies of light-chain amyloid proteins. Scand J Immunol (1981) 0.93